Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACSI: Ticagrelor + aspirin vs aspirin alone after CABG in acute coronary syndrome
2017-001499-43Phase 4Active
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute coronary syndrome (ACS), coronary arteriosclerosis, left main coronary artery disease and 1 more comparing Dual antiplatelet therapy (ticagrelor + aspirin) with Aspirin monotherapy (2 arms). Primary endpoint: Primary composite endpoint. Started Jul 2017; status: active.
02
Drugs
ticagreloraspirin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosisleft main coronary artery diseaseCoronary artery bypass graft (CABG)
Beyond the preview
Go deeper on 2017-001499-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001499-43.